The IBN SINA Pharmaceutical Industry PLC announcements
340 Dhaka Stock Exchange announcements for The IBN SINA Pharmaceutical Industry PLC (IBNSINA) since 2007: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2024 (13).
- Credit Rating Result
Alpha Credit Rating Limited (Alpha Rating) has assigned the Surveillance rating of the Company as "AA+" in the long term and "ST-1" in the short term along with Stable outlook based on the audited financial statements as on June 30, 2024 and relevant qualitative information till December 01, 2024.
- Q1 Financials
(Q1 Un-audited): Consolidated EPS was Tk. 2.72 for July-September 2024 as against Tk. 5.22 for July-September 2023; Consolidated NOCFPS was Tk. 9.71 for July-September 2024 as against Tk. 1.20 for July-September 2023. Consolidated NAV per share was Tk. 114.80 as on September 30, 2024 and Tk. 111.94 as on June 30, 2024.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 12, 2024 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended September 30, 2024.
- Resumption after Record date
Trading of the shares of the company will resume on 28.10.2024.
- Suspension for Record date
Trading of the shares of the company will remain suspended on record date i.e., 27.10.2024.
- Spot News
Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled as per spot settlement cycle with cum benefit from 23.10.2024 to 24.10.2024 and trading of the shares of the company will remain suspended on record date i.e., 27.10.2024.
- Dividend Declaration
The Board of Directors has recommended 63% Cash Dividend for the year ended June 30, 2024. Date of AGM: 24.11.2024, Time: 9:30 AM, Venue: Digital Platform. Record Date: 27.10.2024. The Company has also reported Consolidated EPS of Tk. 21.46, Consolidated NAV per share of Tk. 111.94 and Consolidated NOCFPS of Tk. 12.48 for the year ended June 30, 2024 as against Tk. 19.38, Tk. 96.68 and Tk. 28.08 respectively for the year ended June 30, 2023.
- Price Limit Open
There will be no price limit on the trading of the shares of the Company today (03.10.2024) following its corporate declaration.
- Board Meeting schedule under LR 19(1)
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 02, 2024 at 03:00 PM to consider, among others, audited financial statements of the Company for the year ended June 30, 2024.
- Q3 Financials
(Q3 Un-audited): Consolidated EPS was Tk. 4.31 for January-March 2024 as against Tk. 2.99 for January-March 2023; Consolidated EPS was Tk. 16.23 for July 2023-March 2024 as against Tk. 13.52 for July 2022-March 2023. Consolidated NOCFPS was Tk. 15.50 for July 2023-March 2024 as against Tk. 17.47 for July 2022-March 2023. Consolidated NAV per share was Tk. 106.75 as on March 31, 2024 and Tk. 96.68 as on June 30, 2023.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 20, 2024 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended March 31, 2024.
- Q2 Financials
(Q2 Un-audited): Consolidated EPS was Tk. 6.70 for October-December 2023 as against Tk. 5.90 for October-December 2022; Consolidated EPS was Tk. 11.92 for July-December 2023 as against Tk. 10.53 for July-December 2022. Consolidated NOCFPS was Tk. 11.05 for July-December 2023 as against Tk. 13.92 for July-December 2022. Consolidated NAV per share was Tk. 102.59 as on December 31, 2023 and Tk. 96.68 as on June 30, 2023.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 28, 2024 at 2:45 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended December 31, 2023.
Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.